Airbus Want to Make Flying Cars a Reality
Last year, Airbus announced it was developing a self-flying vehicle. And by the end of 2017, it expects to be finished with its first prototype.
Author: Dylan R
The TSX Venture: Where Penny Stocks Live
Though you can find plenty of microcap stocks in the OTC markets, for those who want access to the largest segment of this species, there is one special place…
The Desperate Need for Cybersecurity
The U.S. can’t afford to have our private and public data compromised by cyber threats and attacks. 2017 will be the year to step up our cybersecurity efforts.
Trump Chills the Gun Market
For eight solid years, investors have watched a very well pronounced phenomenon take hold every time the nation endured another tragic mass shooting… a phenomenon that may be in the past.
The Beauty of Blue Apron
An IPO from meal-kit subscription company Blue Apron will bring life back into the IPO market for 2017.
Trump’s Mandate: More Nukes
Hardly a day goes by that President-elect Donald Trump doesn’t use Twitter to send the nation into a rhetorical tornado regarding the future of defense policy. This week he decided to double-down on the U.S. nuclear arsenal.
Clovis Oncology’s Ovarian Cancer Drug Approved by FDA
Two months ahead of schedule, the U.S. Food and Drug Administration (FDA) just approved Clovis Oncology’s new ovarian cancer drug.
Obama and Jobs: Fact and Fiction
But what is the cold, hard, honest truth of the Obama administration’s accomplishments? Removing all of the emotional background noise, just how good or how bad has Obama’s time in office been?
Dow’s Up, Gold’s Down…
Is this the start of a mega-bull run that’s going to carry us forward from the much-anticipated Dow 20,000 milestone all the way to 30,000? Chances are, no.
Emblem Cannabis is Now Public on the TSX-V
Emblem, a fully integrated medical marijuana, health care, and cannabinoid-based pharmaceutical company, is now publicly traded on the TSX-V.